Others

This group in Kalceks portfolio contains medicines that are not classified here in a separate group –these are several medicines including hormones, vitamins and blood substitutes/perfusion solutions.

Products

Title
Apomorphine injection* (generic of APO-go®)
Strength 5 mg/ml
Volume 10 ml
ATC code N04BC07

ANTI‑PARKINSON DRUGS, DOPAMINERGIC AGENTS

* under development

B-vitamins complex injection  (generic of Milgamma®)
Strength 50 mg / 50 mg / 0.5 mg / 10 mg/ml
Volume 2 ml
ATC code A11DB

VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12

This medicine is used for treatment of haematologic and neurologic symptoms caused by continuous deficiency of vitamins B1, B6 and B12 in adults and children over 12 years.

B-vitamins complex tablets* (generic of Milgamma®)
Volume 100 mg
ATC code A11DB

VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12

This medicine is used for treatment of haematologic and neurologic symptoms caused by continuous deficiency of vitamins B1, B6 and B12 in adults and children over 12 years.

Carbetocin injection*
Strength 0.1 mg/ml
Volume 1 ml
ATC code H01BB03

POSTERIOR PITUITARY LOBE HORMONES

*under development

Furosemide injection*
Strength 10 mg/ml
Volume 2 ml, 5 ml
ATC code C03CA01

DIURETICS, SULFONAMIDES, PLAIN

* under development

Magnesium sulfate heptahydrate injection/infusions
Strength 100 mg/ml*, 200 mg/ml*, 250 mg/ml
Volume 10 ml
ATC code B05XA05

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS, I.V. SOLUTION ADDITIVES

Additional Strength: 500 mg/ml (WHO prequalified) 2 ml and 10 ml

This medicine is used for:
- Treatment and prevention of hypomagnesaemia in clinical conditions which may be associated with magnesium deficiency such as prolonged diarrhoea, diabetes mellitus, malabsorption syndromes, alcoholism, cirrhosis of the liver, during pregnancy and breast-feeding period, in case of renal diseases with polyuria, as well as during administration of “loop” diuretics;
- Prevention and treatment of hypomagnesaemia in patients on total parenteral nutrition;
- Seizure prevention (e. g. epilepsy, uraemia in patients with nephropathy);
- Prevention and treatment of pre-eclampsia and eclampsia in late pregnancy toxemia, as well as to stop spontaneous abortion and preterm labour;
- Treatment of the early stages of arterial hypertension as antispasmodic medicine;
- Prevention of arrhythmias (e. g. torsade de pointes-type arrhythmias, arrhythmias with signs of hypokalemia).

Pantoprazole powder for solution for injection* (generic of Pantozol®)
Volume 40 mg
ATC code A02BC02

DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)

* under development

Pyridoxine hydrochloride injection
Strength 50 mg/ml
Volume 1 ml
ATC code A11HA02

VITAMINS, OTHER PLAIN VITAMIN PREPARATIONS

This medicine is indicated for:
- Vitamin B6 deficiency (including in patients on dialysis);
- sideroblastic anaemia (congenital, secondary, drug- and toxin-induced and other);
- metabolic disorders (increased excretion of xanthurenic acid, primary cystathioninuria, primary hyperoxaluria, primary homocystinuria);
- isoniazid-induced neuropathy; - pyridoxine-dependent seizures in infants;
- premenstrual syndrome.

Sodium chloride injection
Strength 9 mg/ml
Volume 10 ml
ATC code B05XA03

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS, I.V. SOLUTION ADDITIVES

This medicine is used for dissolution or dilution of parenteral drugs. For the wounds, mucous membrane and eyes irrigation.

Sodium oxybate oral solution* (generic of Xyrem®)
Strength 2.5 g/5 ml
Volume 180 ml
ATC code N07XX04

OTHER NERVOUS SYSTEM DRUGS

* under development

Water for injection
Volume 10 ml
ATC code V07AB

ALL OTHER NON-THERAPEUTIC PRODUCTS

This medicine is used for dissolution or dilution of parenteral drugs. Vehicle for administration of compatible drug and electrolyte concentrate,
observing that the osmolarity of whole solution corresponds to 0.85-0.9 % of osmolarity of sodium chloride solution.